Cella Medical Solutions

What Cella Medical Solutions does

Cella Medical Solutions, S.L. (Murcia, Spain; founded 2016 by CEO Darío García Calderón) operates a software-and-service platform that converts volumetric medical imaging (CT, MRI, PET) into patient-specific 3D anatomical models for pre-operative surgical planning and intra-operative guidance in complex soft-tissue procedures. The company's two core products are the Cella Modelling System, which performs AI- and radiomics-driven image segmentation and multimodal fusion and delivers radiologist-validated 3D models under medical-device licensing, and the Cella Surgical Planner, a browser-accessible web platform (planner.cellams.com) that allows surgeons to measure, simulate resections, plan clamping, and virtually navigate the reconstructed anatomy without local software installation. The platform integrates natively with hospital RIS/PACS systems for image transfer and is interoperable with robotic consoles and laparoscopy towers, including a documented integration with the da Vinci Xi surgical robot for hepatobiliary surgery published in the British Journal of Surgery in 2023.

The commercial model is a per-case service wrapped in a subscription / recurring platform relationship, with a freemium entry point (free demo accounts) feeding an enterprise sales motion targeting hospital surgical departments. Target buyers are public and private hospitals and specialty surgeons across general/digestive, hepatobiliary, pancreatic, colorectal, peritoneal/retroperitoneal, urological, thoracic, pediatric, head-and-neck, and cardiac surgery; patients are a secondary persona benefiting from improved consent communication. Geographic footprint is concentrated in Spain — 150+ hospitals and 350+ doctors as disclosed — with a Mexico office and prior trade missions into LATAM (Mexico, Peru, Colombia, Panama, Ecuador) and Sweden. Marketing is content-led, leaning on scientific publications, surgeon testimonials, and case studies rather than paid acquisition.

Capital structure is founder-controlled: the company is privately held as a Spanish sociedad limitada, with no disclosed PE/VC ownership beyond a 2022 round including Moira Capital Desarrollo and SICC alongside CDTI (approximately €5.37M). Operating capital has been substantially supplemented by Spanish and European public funding — including CDTI (Health Mission, Direct Line of Innovation), MICIU/AEI, and ERDF programmes — supporting R&D in radiomics and AI applications and the conversion of the 3DMSP solution into a certified medical device. Certifications held include UNE-EN ISO 13485:2018 (medical-device QMS), ISO 27001, ENS, and GDPR compliance, providing the regulatory scaffolding required to sell into European public-hospital procurement.

Name

Cella Medical Solutions

Legal name

CELLA MEDICAL SOLUTIONS, S.L.

Website

https://cellams.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Cella Medical Solutions is a Spanish healthtech firm providing an AI- and radiomics-driven 3D surgical planning platform that converts CT, MRI, and PET imaging into patient-specific anatomical models for hospitals and specialty surgeons performing complex soft-tissue procedures, with operations in Spain and a LATAM office in Mexico.

Ownership category

akta.pro rank

Product category

Surgical Planning Software

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industries

Medical Imaging AI (HDAAAEAH), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)

Keywords

• 3D surgical planning
• Medical image segmentation
• Patient-specific anatomical models
• Radiomics AI software
• Preoperative surgical simulation

Headquarters

HQ city

Murcia

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. 3D Model Subscription/Per-case Service: Web-based platform providing patient-specific 3D models for surgical planning. Hospitals and surgeons access models through the Cella Surgical Planner platform. The company handles the entire process from medical image upload to clinical validation by radiologists.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

Cella Medical Solutions provides an AI- and radiomics-powered 3D surgical planning platform that converts patient CT, MRI, and PET imaging into radiologist-validated, patient-specific 3D anatomical reconstructions. Its web-based Cella Surgical Planner and Cella Modelling System support pre-operative planning, intra-operative guidance, and surgical simulation for complex soft tissue procedures across multiple specialties, and integrate with hospital RIS/PACS systems and surgical robotics (da Vinci Xi).

Product overview

Cella Medical Solutions offers a comprehensive 3D surgical planning ecosystem consisting of two core products: the Cella Modelling System (customized 3D models with medical device licensing) and the Cella Surgical Planner (web-based visualization tool for those models). The workflow involves medical image segmentation using AI algorithms, multimodal fusion of CT/MRI/PET data, radiologist validation, and delivery of patient-specific 3D reconstructions. Additional offerings include virtual reality planning environments and 3D-printed physical models. The solution integrates with hospital RIS/PACS systems and surgical robotics platforms (da Vinci Xi) to provide both preoperative planning and intraoperative guidance.

Differentiator

Problem solved

Functional benefit

Products and services

• Cella Surgical Planner Web-based 3D surgical planning platform accessible from any browser without software installation, providing advanced tools for anatomical visualization, measurements, virtual navigation, resection planning, clamping simulation, vascular studies, and surgical planning across multiple specialties.
• Cella Modelling System Customized 3D anatomical model service, holding medical device licensing, that delivers high-precision segmentation and multimodal medical image fusion (CT, MRI, PET) validated by in-house radiologists for use in surgical planning.
• Patient-Specific 3D Anatomical Models Interactive 3D reconstructions validated by radiologists that provide complete 360-degree understanding of patient anatomy for surgical planning and intraoperative guidance.
• Virtual Reality Surgical Planning

Quantifiable outcome

• Supports over 15,000 complex surgeries with 3D planning technology
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature6 records

Partnerships

One partnership is on record.

• B.BrauncoreStrategic or Co-development Partner · 10 July 2025Strategic partnership to integrate Cella's 3D anatomical models into B.Braun's laparoscopic surgery systems. The collaboration aims to advance high-complexity laparoscopic surgery by combining B.Braun's surgical equipment with Cella's patient-specific 3D visualization technology for real-time intraoperative guidance.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Materialise (Mimics): Materialise's Mimics platform converts medical imaging into patient-specific 3D anatomical models and 3D-printed surgical guides, with FDA-cleared workflows — directly comparable to Cella's Cella Modelling System across orthopedics, CMF, and complex surgery planning.
• Brainlab: Brainlab offers 3D surgical planning, image-guided surgery, and intraoperative visualization software widely used in neurosurgery, spine, and increasingly in soft-tissue specialties — a direct competitor to Cella in patient-specific 3D modeling and surgical navigation.
• Surgical Theater: Surgical Theater provides VR-based 360° surgical planning and rehearsal using patient-specific 3D reconstructions — overlapping with Cella's VR surgical planning module and intraoperative visualization offering.
• Visible Patient: Visible Patient (France) creates patient-specific 3D anatomical models from CT/MRI for surgical planning in liver, lung, and kidney surgery — a European peer with the same target specialties and clinical use cases as Cella.
• axial3D: axial3D offers AI-driven 3D anatomical model production and surgical planning services for hospitals, with a similar per-case / SaaS model to Cella and growing focus on pre-operative planning across multiple surgical specialties.

Broad incumbents

• Siemens Healthineers (syngo.via): Siemens Healthineers' syngo.via and AI-Rad Companion provide advanced 3D visualization and AI segmentation for CT/MRI — a broad incumbent with deep hospital relationships whose offerings overlap with Cella's but are bundled with Siemens imaging hardware.
• Philips (IntelliSpace Portal): Philips IntelliSpace Portal offers advanced 3D rendering, multi-modality fusion, and AI-based analysis — a broad incumbent competing for the same hospital budgets as Cella with the advantage of a global installed base and integrated PACS.
• GE HealthCare (AW Workstation, Edison): GE HealthCare's AW Workstation and Edison AI platform provide multi-modality 3D visualization, segmentation, and clinical AI for surgical planning — a broad incumbent whose hospital footprint and bundled offerings compete directly with Cella.

Emerging players

• 3D Systems (Healthcare): 3D Systems' Healthcare solutions include patient-specific 3D-printed anatomical models and virtual surgical planning — an adjacent peer whose 3D-printed models offering overlaps with Cella's physical 3D-printed anatomical models add-on.
• Innersight Labs: Innersight Labs (UK) develops AI-driven 3D surgical planning software for cardiac and structural heart procedures — a comparable emerging player focused on a high-value surgical segment that intersects with Cella's complex-surgery focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/CellaMedical3D
• YouTubeyoutube.com/channel/UC5IPxwV6L07dgBG0JAj-kdQ
• Facebookfacebook.com/CellaMedical3D
• LinkedInlinkedin.com/company/cellamedical3d
• Instagraminstagram.com/cellamedical3d

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cella Medical Solutions